These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 13860062)

  • 1. [The treatment of ascitic cirrhosis with aldosterone antagonists (spirolactones). Clinical and metabolic study of 13 cases treated with spironolactone].
    ALBEAUX-FERNET M; CHABOT J; ROMANI JD
    Sem Hop; 1962 Jul 4-10; 38():2207-22. PubMed ID: 13860062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spirolactones in the treatment of ascitic cirrhoses (26 cases)].
    VACHON A; BESSET C; ARCADIO F; JOUD R
    Lyon Med; 1961 May; 93():1029-43. PubMed ID: 13779510
    [No Abstract]   [Full Text] [Related]  

  • 3. [The place of spirolactones in the treatment of ascitogenic cirrhosis].
    MINICONI P
    Alger Medicale; 1962 Apr; 66():481-92. PubMed ID: 14474323
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spirolactone treatment of liver cirrhosis with edema and ascites].
    OFSTAD J; SIGSTAD H
    Nord Med; 1962 Jan; 67():21-4. PubMed ID: 14481210
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transitory hyperazotemia during spirolactone treatment in a patient of cirrhosis].
    JUSTIN-BESANCON L; LAROCHE C; NENNA A; ETIENNE JP; LEBORGNE P
    Bull Mem Soc Med Hop Paris; 1960 Nov 18-25; 76():1225-9. PubMed ID: 13791129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trials of treatment of cirrhotic ascites with a spirolactone. Apropos of 7 cases].
    LEVRAT M; BRETTE R; FRANCOIS B; TISSOT A; MESTRALLET G
    Lyon Med; 1961 May; 93():1115-23. PubMed ID: 13761576
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comments on the use of spirolactones in the treatment of ascitic cirrhosis (5 cases)].
    GRILLIAT JP; MARCHAL C; ANTOINE ; SAPELIER P; KIFFER B
    Rev Med Nancy; 1961; 86():801-20. PubMed ID: 13901929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spirolactones. Their use in the treatment of cardiac and cirrhotic edemas (apropos of 6 case reports)].
    JUSTIN-BESANCON L; LAROCHE C; NENNA A; ETIENNE JP; CREMER G
    Sem Hop; 1960 Dec; 36():3083-97. PubMed ID: 13791128
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spirolactones in the treatment of ascitogenic hepatic cirrhosis. Clinical and biological effects].
    BONINI A
    Minerva Med; 1962 Jun; 53():1990-4. PubMed ID: 13871015
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spirolactone, an aldosterone-antagonistic steroid. Illustration of its effects on a patient with liver cirrhosis].
    EILERSEN P; HEMPEL-JORGENSEN P
    Ugeskr Laeger; 1960 Feb; 122():252-6. PubMed ID: 13819718
    [No Abstract]   [Full Text] [Related]  

  • 11. [ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CIRRHOTIC ASCITIS].
    GARCIA-RAMOSARRIAGA J
    Acta Med Tenerife; 1963; 20():101-4. PubMed ID: 14093724
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aldactone (antialdosterone SC-9420) in the treatment of the edema of cardiac and cirrhoticpatients. Bioclinical study. I].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E
    Ann Biol Clin (Paris); 1962; 20():497-524. PubMed ID: 14483184
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of SC 9420, mercurial diuretic and hydrochlorothiazide on electrolyte excretion in liver cirrhosis].
    VELASCO M; KATZ R; KATZ E; GARCIA H; GAZMURI R
    Rev Med Chil; 1959 Dec; 87():946-51. PubMed ID: 13841591
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of spironolactone in 2 cases of ascitic alcoholic cirrhosis refractory to the usual treatment].
    TOLOT F; ROULLET A; SALLE B; JOUD R; POULET R; EVREUX P
    Lyon Med; 1961 May; 93():1139-50. PubMed ID: 13777266
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined diuretic and steroid therapy in cirrhosis with ascites.
    MORRISON RS; CHALMERS TC
    Ann N Y Acad Sci; 1960 Oct; 88():907-14. PubMed ID: 13772890
    [No Abstract]   [Full Text] [Related]  

  • 16. Spironolactone (Aldactone) therapy for ascites due to cirrhosis of the liver.
    LOCKWOOD CH
    Can Med Assoc J; 1961 Sep; 85(11):631-7. PubMed ID: 13763007
    [No Abstract]   [Full Text] [Related]  

  • 17. [OUR EXPERIENCE IN THE TREATMENT OF PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS WITH ALDOSTERONE INHIBITORS].
    KNEZEVIC S; HAHN A
    Lijec Vjesn; 1963 Oct; 85():1085-93. PubMed ID: 14097613
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of the hydrosaline retention in hepatic cirrhosis with spironolactone].
    VELASCO M; GAZMURI R; KATZ R
    Rev Med Chil; 1961 Oct; 89():846-51. PubMed ID: 13925219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cirrhotic edemas and spironolactone].
    ALBAHARY C; POMMEY B
    Concours Med; 1962 Mar; 84():1759-66. PubMed ID: 13860028
    [No Abstract]   [Full Text] [Related]  

  • 20. [Spirolactone (Aldactone) in ascites caused by liver cirrhosis].
    van DOMMELEN C; LE POOLE A; VAANDRAGER H; SCHOPMAN W; WADMAN SK
    Ned Tijdschr Geneeskd; 1962 Jul; 106():1481-6. PubMed ID: 13887135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.